Clinical Trial Update: Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients [Phase 3]

View source ↗

Summary

Clinical trial update reports the completion of a Phase 3 study evaluating rimonabant in drug-naive patients with Type 2 Diabetes Mellitus. The summary snippet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED